Antibacterial use in the Faroe Islands, Iceland, and Denmark 1999-2011.

Marita Debess Magnussen, Thorolfur Gudnason, Ulrich Stab Jensen, Niels Frimodt-Møller, Karl G Kristinsson
{"title":"Antibacterial use in the Faroe Islands, Iceland, and Denmark 1999-2011.","authors":"Marita Debess Magnussen,&nbsp;Thorolfur Gudnason,&nbsp;Ulrich Stab Jensen,&nbsp;Niels Frimodt-Møller,&nbsp;Karl G Kristinsson","doi":"10.3109/00365548.2014.902538","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Faroe Islands, Iceland, and Denmark are neighbouring Nordic countries with great ethnic, cultural, and political similarities and are relatively homogeneous. Important information about prescribing practices can be obtained by comparing the antibacterial use in these countries. The objective was to describe, compare, and analyse the use of systemic antibacterial agents in these countries during the y 1999-2011.</p><p><strong>Methods: </strong>Data were obtained from the Faroe Islands, Iceland, and Denmark on systemic antibacterial use and expressed in defined daily dosages (DDD). Prescription data were also obtained for specific age groups.</p><p><strong>Results: </strong>The total antibacterial use for the y 1999-2011 varied markedly between the 3 countries, with a mean use of 21.8 DDD/1000 inhabitants/day (DID) in Iceland, 17.7 in the Faroe Islands, and 16.3 in Denmark. The total use remained fairly constant over the years in the Faroe Islands and Iceland, whereas in Denmark it increased gradually from 13.5 DID in 1999 to 19.5 DID in 2011. The higher use in Iceland can be explained by much higher consumption of tetracyclines. There was also considerable variation in the use of individual penicillins and macrolides between the countries.</p><p><strong>Conclusions: </strong>Despite the great ethnic and cultural similarities of these 3 countries, we found marked differences in total antibacterial use and important differences in the use of individual antibacterials.</p>","PeriodicalId":21541,"journal":{"name":"Scandinavian Journal of Infectious Diseases","volume":"46 7","pages":"502-7"},"PeriodicalIF":0.0000,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/00365548.2014.902538","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/00365548.2014.902538","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/5/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Background: The Faroe Islands, Iceland, and Denmark are neighbouring Nordic countries with great ethnic, cultural, and political similarities and are relatively homogeneous. Important information about prescribing practices can be obtained by comparing the antibacterial use in these countries. The objective was to describe, compare, and analyse the use of systemic antibacterial agents in these countries during the y 1999-2011.

Methods: Data were obtained from the Faroe Islands, Iceland, and Denmark on systemic antibacterial use and expressed in defined daily dosages (DDD). Prescription data were also obtained for specific age groups.

Results: The total antibacterial use for the y 1999-2011 varied markedly between the 3 countries, with a mean use of 21.8 DDD/1000 inhabitants/day (DID) in Iceland, 17.7 in the Faroe Islands, and 16.3 in Denmark. The total use remained fairly constant over the years in the Faroe Islands and Iceland, whereas in Denmark it increased gradually from 13.5 DID in 1999 to 19.5 DID in 2011. The higher use in Iceland can be explained by much higher consumption of tetracyclines. There was also considerable variation in the use of individual penicillins and macrolides between the countries.

Conclusions: Despite the great ethnic and cultural similarities of these 3 countries, we found marked differences in total antibacterial use and important differences in the use of individual antibacterials.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
1999-2011年法罗群岛、冰岛和丹麦的抗菌药物使用情况。
背景:法罗群岛、冰岛和丹麦是邻近的北欧国家,在民族、文化和政治上有很大的相似性,而且相对来说是同质的。通过比较这些国家的抗菌药物使用情况,可以获得关于处方做法的重要信息。目的是描述、比较和分析这些国家1999-2011年期间全身性抗菌药物的使用情况。方法:从法罗群岛、冰岛和丹麦获得系统抗菌药物使用的数据,并以限定日剂量(DDD)表示。还获得了特定年龄组的处方数据。结果:3国1999-2011年抗菌药物总使用量差异显著,冰岛平均使用量为21.8 DDD/1000居民/天,法罗群岛为17.7 DDD/1000居民/天,丹麦为16.3 DDD/1000居民/天。法罗群岛和冰岛的总使用量多年来保持相当稳定,而丹麦的使用量从1999年的13.5 DID逐渐增加到2011年的19.5 DID。冰岛的高使用率可以用四环素的高消费量来解释。各国在使用个别青霉素类和大环内酯类药物方面也存在相当大的差异。结论:尽管这三个国家在种族和文化上有很大的相似性,但我们发现在抗菌药物的总使用上存在显著差异,在单个抗菌药物的使用上存在重要差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
4-8 weeks
期刊最新文献
Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana. Performance of the Simplexa™ Flu A/B & RSV Direct Kit on respiratory samples collected in saline solution. Elevated levels of circulating histones indicate disease activity in patients with hand, foot, and mouth disease (HFMD). The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway. Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1